We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

SSB and G-Con Manufacturing Announce Global Collaboration

SSB and G-Con Manufacturing Announce Global Collaboration

SSB and G-Con Manufacturing Announce Global Collaboration

SSB and G-Con Manufacturing Announce Global Collaboration

Read time:

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "SSB and G-Con Manufacturing Announce Global Collaboration"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Sartorius Stedim Biotech (SSB) and G-Con have agreed to a global collaboration to offer highly advanced and flexible production platforms for the biopharmaceutical manufacturing industry.

The new product line will leverage G-Con Manufacturing’s novel modular, mobile clean-room “pods” and Sartorius Stedim Biotech’s well-established broad single-use and reusable product portfolio to create a totally integrated production process platform.

SSB has incorporated its products into unit operations for media/buffer preparation, seed fermentation, cell cultivation and harvesting, ultra-diafiltration, membrane chromatography and viral clearance for biopharmaceutical development and manufacturing.

Combining SSB’s technology with G-Con’s modular, scalable and flexible pod platform will provide the biopharmaceutical manufacturing industry with an unparalleled set of cost-effective, “plug and play” tools for next-generation manufacturing facilities.

Maik Jornitz, SSB’s Senior Vice President of Marketing for Bioprocess Solutions, stated, “The combined product portfolio will fundamentally change the way biopharmaceutical manufacturing processes will be designed and configured. Our Integrated Solutions unit will implement G-Con’s platform of modular clean-room systems into their designs. In addition, our teams will benefit from G-Con’s engineering and design expertise. Our vision is to create standardized unit operations, implemented into the self-contained G-Con modules. These modules can be used as individual process units or joined to an entire process.”

Barry Holtz, President of G-Con Manufacturing, stated, “Our common goal is to combine our complementary expertise to develop revolutionary solutions for the next generation of flexible, single-use manufacturing concepts. We couldn’t be more excited about having an agreement with a leader in single-use products like Sartorius Stedim Biotech.”

Effective immediately, G-Con’s modular containment units are available through SSB’s Integrated Solutions unit and will be rolled out globally in early 2012.

Jornitz commented: “We do not want to delay the availability of the G-Con units and therefore decided to have our Integrated Solutions unit utilize the containment systems and G-Con’s engineering capabilities now. The global launch through our sales organizations will follow.”